ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm PPS nasal spray to treat Allergic Rhinitis
Published: 19/08/16, 09:42am (AEST)•3 pages